Dr Koen Pouwels
Contact information
Koen Pouwels
Phd
Senior Researcher
Koen joined Oxford Population Health's Health Economics Research Centre (HERC) as a senior researcher in January 2019. His current work focuses on infectious disease and antimicrobial resistance modelling, randomised trial designs, economic evaluations alongside trials, incorporating long-term effects into economic evaluations, and statistical approaches to address time-dependent confounding in burden of illness studies.
His work has directly informed national COVID-19 mitigation and testing strategies, vaccination policies against various infectious diseases, as well as national targets for antibiotic prescribing in primary care.
Prior to joining HERC, Koen worked at Public Health England on projects using mathematical, statistical and machine learning approaches to understand and predict the development and health-economic impact of healthcare associated infections and antimicrobial resistance. Before coming to the UK, he obtained his PhD in epidemiology at the University of Groningen where he was also involved in a number of economic evaluations of vaccinations against infectious diseases.
Recent publications
-
SARS-CoV-2, influenza A/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022/23 winter season in the UK: a longitudinal surveillance cohort.
Journal article
Dietz E. et al, (2024), BMC Med, 22
-
Reducing the antigen prevalence target threshold for stopping and restarting mass drug administration for lymphatic filariasis elimination: A model-based cost-effectiveness simulation in Tanzania, India, and Haiti
Journal article
POUWELS K., (2024), Clinical Infectious Diseases
-
Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review.
Journal article
Allel K. et al, (2024), BMJ Glob Health, 9
-
System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework.
Journal article
AMR-X Collaborators None., (2024), Lancet Microbe
-
Projecting health and economic impacts of Lassa vaccination campaigns in West Africa
Preprint
Smith DRM. et al, (2024)